Compugen Statistics
NASDAQ: CGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.84-0.04 (-2.13%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Compugen by the numbers
Compugen has a market capitalization of $174.3 million based on 94.72M shares outstanding. Its trailing P/E ratio is 4.7. The stock trades 14.2% below its 50-day average and 20.0% below its 200-day average.
Average daily trading volume is 223.56K shares, or about $411,345 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CGEN valuation vs. peer median
| Metric | CGEN | Peer median | Difference |
|---|---|---|---|
| Market cap | $174.29M | $186.01M | -6% |
| Avg. volume | 223.56K | 931.37K | -76% |
Peer median across 8 companies: IKT, ARTV, LCTX, CABA, PALI, IPSC, STRO, TARA.
Valuation
- Market cap
- $174.29M
- P/E (TTM)
- 4.72
- Price / sales (latest FY)
- 2.40
- EPS (TTM)
- $0.39
- Shares outstanding
- 94.72M
Price and trading
- Previous close
- 1.88
- Open
- 1.85
- Day range
- 1.81 – 1.88
- 52-week range
- 1.43 – 3.24
- 52-week change
- +20.26%
- Beta
- —
- Volume
- 188.25K
- Average volume
- 223.56K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 174.29M
- Pe
- 4.72
- Forward Pe
- -5.26
- Eps
- 0.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.24
- Week52 Low
- 1.43
- Avg Volume
- 223.56K
- Shares Outstanding
- 94.72M
- Ma50
- 2.14
- Ma200
- 2.30
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -43.21%
- Pct From52w Low
- 28.67%